Back

The risk factors for in-stent restenosis following drug-eluting stent implantation in end-stage renal disease patients receiving renal replacement therapy

30 August 2024 (09:00 - 09:30)
Organised by: Logo
Congress Presentation Part of: The association of diabetes and renal disease with poor percutaneous coronary intervention outcomes Restenosis ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Mr Thanaphruet Issarawattana

Maharaj Nakhon Si Thammarat Hospital, Nakhon Si Thammarat (Thailand)

5 More presentations in this session

Presentation thumbnail
Influence of acute kidney injury and chronic kidney disease on 3-year clinical outcomes in patients with AMI treated by contemporary PCI and optimal medical therapy; insights from J-MINUET study
Professor Y. Ozaki (Aichi, JP)
Abstract Slides Video
Presentation thumbnail
A simplified bedside model for acute kidney injury prediction after percutaneous coronary intervention
Assistant Professor D. Balanescu (Rochester, US)
Abstract Slides Video
Presentation thumbnail
Comparison of clinical outcomes in diabetic and non-diabetic patients undergoing coronary bifurcation stenting
Assistant Professor S. Lim (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Long-term outcome of diabetic patients after unprotected left main percutaneous coronary interventions
Doctor O. Nemeth (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
Comparative clinical outcomes of amphilimus-eluting stents in diabetic versus non-diabetic patients
Assistant Professor J. Kim (Seoul, KR)
Abstract Slides Video

Access the full session

Session thumbnail
The association of diabetes and renal disease with poor percutaneous coronary intervention outcomes

The Event

Event poster

ESC Congress 2024

30 August 2024 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Clinical outcomes after stent thrombosis in patients with hemodialysis: from the Real-ST registry
thumbnail
Congress Presentation
Long-term outcomes following drug-coated balloons versus thin-strut drug-eluting stents for treatment of in-stent restenosis in chronic kidney failure
thumbnail
Congress Session
Strategies and outcomes in in-stent restenosis

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources